In the R60,000-crore domestic drug market, Sun Pharmaceutical is on the brink of crossing GlaxoSmithKline to become the third largest…
Drug applications from all of Ranbaxy Labs? manufacturing facilities must now go through an arduous auditing journey before the US…
The government has made it mandatory for pharmaceutical companies sponsoring clinical trials in the country to pay financial compensation to…
The long-winding regulatory crisis faced by Ranbaxy Labs Ltd, India?s second largest drug maker by sales, has culminated in a…
Buoyed by the response to its tie-up with Eli Lily, leading Indian drugmaker Lupin is considering more such marketing and…
The Ranbaxy Laboratories stock tanked over 6.5% on Friday on the Bombay Stock Exchange, its steepest fall in almost 10…
In order to give a push to its domestic sales, Merck, the Indian arm of $12-billion German pharma giant Merck,…
How can Pfizer gain from Ranbaxy Lab?s generic version of cholesterol drug Lipitor when both are ferociously competing products in…
Not only did the commercial success of his films Ready and Bodyguard make Bollywood actor Salman Khan the bigger star…
Indian pharma market has touched a new milestone in the calendar year 2011 by crossing the R60,000-crore mark for the…
India was one of the top three sources for counterfeit goods in 2011, according to the US Customs and Border…
Regulatory hiccups may keep Ranbaxy Laboratories from milking Lipitor?s generic exclusivity opportunity to the fullest in the US, but the…
In the not-too-distant future, diabetics in urban India could be discussing ?subscription plans?, ?top-ups & value-added services? and ?need for…
The Mexico plant of the second largest domestic pharma firm by sales, Dr Reddy?s Labs, which received a warning letter…
The apparent high cost of the ?consent decree? Ranbaxy Laboratories signed with US Food and Drug Administration may prove to…
In a surprising turn of events, the pharma multinationals have sought that government should not do away with price control…
It?s a dose of strong medicine for drug firms. The government is in the process of formulating a new set…
A whopping 89% of the country?s population at the bottom of pyramid, which earn less than R100 a day, has…
